Radiation Therapy
Services, Inc. (Nasdaq: RTSX), a leading operator of radiation therapy
centers, announced today that Medical Director and Secretary James
Rubenstein, M.D. has been appointed to the Editorial Board of the American
Journal of Clinical Oncology.
As an editor, Dr. Rubenstein will assist in reviewing incoming articles
and soliciting high quality submissions from colleagues and trainees. The
editorial board includes a large number of distinguished surgeons,
radiation oncologists, medical oncologists, GYN oncologists, pediatric
oncologists, and others who are internationally recognized for expertise in
their fields. The journal emphasizes translational research, outcome
studies, and cost utility analyses, and includes opinion pieces and review
articles.
David Wazer, Editor in Chief of the American Journal of Clinical
Oncology, said, "We believe Dr. Rubenstein will bring tremendous value to
our editorial board as a practicing physician experienced in treating
patients with the latest radiation oncology modalities. He is regarded as
one of the top radiation oncologists and a leader in his field. We are
thrilled that he has accepted our offer to join the Editorial Board."
James Rubenstein, M.D., Radiation Therapy's Medical Director, said,
"The opportunity to join the Editorial Board of such a prestigious medical
journal is truly an honor. I look forward to contributing to the review of
research within our field and helping to ensure the Journal continues to
publish some of the highest-quality articles in radiation oncology."
About the American Journal of Clinical Oncology
American Journal of Clinical Oncology is a peer-reviewed,
multidisciplinary journal that publishes original articles on the latest
multi-modality scientific issues related to the locoregional management of
cancer. The Journal's intent is to give priority to submitted materials
that deal with the surgical, radiotherapeutic and chemotherapeutic
management of locoregional cancer.
About Radiation Therapy Services
Radiation Therapy Services, Inc., which operates radiation treatment
centers primarily under the name 21st Century Oncology, is a provider of
radiation therapy services to cancer patients. The Company's 70 treatment
centers are clustered into 23 local markets in 14 states, including
Alabama, Arizona, California, Delaware, Florida, Kentucky, Maryland,
Massachusetts, Nevada, New Jersey, New York, North Carolina, Rhode Island
and West Virginia. The Company is headquartered in Fort Myers, Florida.
More information about the Company can be found at its Web site
sec. RTSXG
This release may contain forward-looking statements about the Company's
future plans, expectations and objectives. Words such as "may," "will,"
"expect," "intend," "anticipate," "plan," "believe," "seek," "could" and
"estimate" and variations of these words and similar expressions are
intended to identify forward-looking statements. These forward-looking
statements are not historical facts and are subject to risks and
uncertainties that could cause the actual results to differ materially from
those projected in these forward-looking statements including, but not
limited to those risk factors described in the "Risk Factors" section and
other information in the Company's most recently filed quarterly report on
Form 10-Q and annual report on Form 10-K, as well as the Company's other
filings with the Securities and Exchange Commission which are available on
the SEC's website at sec. Readers of this release are cautioned not
to place undue reliance on forward-looking statements. The Company
undertakes no obligation to publicly update or revise the forward-looking
statements contained herein to reflect changed events or circumstances
after the date of this release.
Radiation Therapy Services, Inc.
rtsx